BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16736409)

  • 1. Chronic kidney disease epidemics--a gap in effectiveness: the distance between potential and actual treatment benefits.
    Zoccali C; Cambareri F
    J Nephrol; 2006; 19(2):131-4. PubMed ID: 16736409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertensive women with the metabolic syndrome are at risk of renal insufficiency more than men in general population.
    Korhonen P; Aarnio P; Vesalainen R; Saaresranta T; Kautiainen H; Järvenpää S; Kantola I
    J Hum Hypertens; 2009 Feb; 23(2):97-104. PubMed ID: 18784736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney disease and associated risk factors--United States, 1999-2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(8):161-5. PubMed ID: 17332726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M; Noberasco G; Re M; Filippi A; Gallina AM; Weiss U; Cannavò R; Ravera G; Cricelli C; Deferrari G
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of the metabolic syndrome in pediatrics: a blessing and a curse.
    Battista M; Murray RD; Daniels SR
    Semin Pediatr Surg; 2009 Aug; 18(3):136-43. PubMed ID: 19573755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome and chronic kidney disease: a Japanese perspective on a worldwide problem.
    Iseki K
    J Nephrol; 2008; 21(3):305-12. PubMed ID: 18587718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and cardiovascular risk: implications for clinical practice.
    Eddy DM; Schlessinger L; Heikes K
    Int J Obes (Lond); 2008 May; 32 Suppl 2():S5-10. PubMed ID: 18469838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bariatric surgery for morbid obesity: risks and benefits in chronic kidney disease patients.
    Zalesin KC; McCullough PA
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):403-17. PubMed ID: 17045226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A; Sowers JR; McCullough PA; Roberts T; McFarlane SI; Chen SC; Li S; Wang C; Collins AJ; Bakris GL;
    Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The metabolic syndrome and chronic kidney disease.
    Peralta CA; Kurella M; Lo JC; Chertow GM
    Curr Opin Nephrol Hypertens; 2006 Jul; 15(4):361-5. PubMed ID: 16775449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of guidelines for the management of hypertension in cardiovascular risk scoring of renal patients.
    Mazzaferro S; Barresi G; Baldinelli M; Malagnino E; Matera G; Otranto G; Pasquali M; Pugliese F
    Clin Ter; 2006; 157(4):327-32. PubMed ID: 17051969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome, C-reactive protein, and chronic kidney disease in nondiabetic, nonhypertensive adults.
    Lee JE; Choi SY; Huh W; Kim YG; Kim DJ; Oh HY
    Am J Hypertens; 2007 Nov; 20(11):1189-94. PubMed ID: 17954366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.
    Whaley-Connell AT; Sowers JR; Stevens LA; McFarlane SI; Shlipak MG; Norris KC; Chen SC; Qiu Y; Wang C; Li S; Vassalotti JA; Collins AJ;
    Am J Kidney Dis; 2008 Apr; 51(4 Suppl 2):S13-20. PubMed ID: 18359403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A quick guide to evidence-based chronic kidney disease care for the primary care physician.
    Fox CH; Voleti V; Khan LS; Murray B; Vassalotti J
    Postgrad Med; 2008 Jul; 120(2):E01-6. PubMed ID: 18654062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.